Cardinal Health, Inc.
CAH · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.23 | -0.80 | 0.59 | -5.10 |
| FCF Yield | 2.32% | 3.23% | 8.44% | -1.74% |
| EV / EBITDA | 45.88 | 68.46 | 39.55 | 43.93 |
| Quality | ||||
| ROIC | 3.38% | 1.81% | 4.06% | 3.50% |
| Gross Margin | 3.62% | 3.66% | 3.87% | 3.51% |
| Cash Conversion Ratio | 2.14 | 6.28 | 5.74 | -1.00 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.71% | 2.78% | 3.79% | 4.79% |
| Free Cash Flow Growth | -33.20% | -53.60% | 659.32% | 71.27% |
| Safety | ||||
| Net Debt / EBITDA | 4.87 | 8.27 | 4.60 | 5.14 |
| Interest Coverage | 8.35 | 5.78 | 9.86 | 15.69 |
| Efficiency | ||||
| Inventory Turnover | 3.51 | 3.44 | 3.26 | 3.15 |
| Cash Conversion Cycle | -8.80 | -7.96 | -7.64 | -4.15 |